Stockreport

SciNeuro and Novartis sign global licensing deal for Alzheimer's antibody [Yahoo! Finance]

Avidity Biosciences, Inc.  (RNA) 
PDF The agreement will leverage SciNeuro's proprietary blood-brain barrier shuttle technology, aiming to deliver potential differentiation from current amyloid beta agents [Read more]